Edwards Lifesciences has penned a deal to buy Valtech Cardio for up to $690 million, less than the heart valve company looked set to be acquired for last year.
HeartWare was hit with a Class I recall for its ventricular assist device pumps, adding to its laundry list of woes months after Medtronic acquired the company.
